Powder: -20°C for 3 years | In solvent: -80°C for 1 year
LTB4 antagonist 2, a carboxamide-acid compound, serves as an antagonist to leukotriene B4 (LTB4), possessing potential anti-inflammatory properties. It exhibits high affinity for the LTB4 receptor, with an inhibitory concentration (IC50) of 439 nM [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 1,970.00 | |
50 mg | 8-10 weeks | $ 2,580.00 | |
100 mg | 8-10 weeks | $ 3,400.00 |
Description | LTB4 antagonist 2, a carboxamide-acid compound, serves as an antagonist to leukotriene B4 (LTB4), possessing potential anti-inflammatory properties. It exhibits high affinity for the LTB4 receptor, with an inhibitory concentration (IC50) of 439 nM [1]. |
Targets&IC50 | LTB4:439 nM |
In vitro | LTB4 antagonist 2 (compound 24c), at concentrations of 0.1 μM and 10 μM, exhibits a specific binding inhibition of LTB4, achieving inhibition rates of 25% and 95%, respectively [1]. |
Molecular Weight | 445.46 |
Formula | C26H23NO6 |
CAS No. | 2929239-85-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
LTB4 antagonist 2 2929239-85-8 GPCR/G Protein Leukotriene Receptor inhibitor inhibit